title: Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
authors.forename: N A Mark
authors.initials: NA
authors.lastname: Estes
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Kovacs
authors.forename: Aaron L
authors.initials: AL
authors.lastname: Baggish
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Myerburg
mesh_terms: D026683:Advisory Committees / Q000592:standards*; D000572:American Heart Association; D056352:Athletes; D002309:Cardiology / Q000379:methods / Q000592:standards*; D018376:Cardiovascular Abnormalities / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D058573:Performance-Enhancing Substances / Q000009:adverse effects / Q000032:analysis / Q000592:standards*; D017410:Practice Guidelines as Topic / Q000592:standards; D014481:United States / Q000453:epidemiology
chemical_list: D058573:Performance-Enhancing Substances
keywords: AHA Scientific Statements; athletes; cardiovascular abnormalities; drugs; performance-enhancing substances